March 1 (Reuters) - Oncogenex Pharmaceuticals Inc
Advertisement
* Oncogenex Pharma says Achieve Life Science and co announce strategic collaboration with National Institutes of Health to advance development of cytisine
* Oncogenex Pharmaceuticals Inc says results of initial study are expected in second-quarter of 2017
* Oncogenex Pharmaceuticals Inc says multiple key cytisine development and regulatory milestones expected in 2017 Source text for Eikon: Further company coverage: